These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 9597241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH.
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [Abstract] [Full Text] [Related]

  • 3. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS, Remschmidt C, Werner S, Behnke M, Schwab F, Werner G, Gastmeier P, Leistner R.
    Antimicrob Resist Infect Control; 2018 Mar; 7():133. PubMed ID: 30459945
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
    Stosor V, Peterson LR, Postelnick M, Noskin GA.
    Arch Intern Med; 1998 Mar 09; 158(5):522-7. PubMed ID: 9508230
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA, Akalin H, Kirkizlar O, Ozkalemkas F, Ozkocaman V, Kazak E, Ozakin C, Bulbul EN, Ozboz ES, Ali R.
    Leuk Res; 2020 Dec 09; 99():106463. PubMed ID: 33130331
    [Abstract] [Full Text] [Related]

  • 8. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
    da Silva NS, Muniz VD, Estofolete CF, Furtado GH, Rubio FG.
    Am J Infect Control; 2014 Apr 09; 42(4):389-92. PubMed ID: 24679566
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of 117 episodes of enterococcal bacteremia: Study of epidemiology, microbiology and antimicrobial susceptibility].
    Manassero NC, Navarro M, Rocchi M, di Bella H, Gasparotto AM, Ocaña Carrizo AV, Novillo F, Furiasse D, Monterisi A.
    Rev Argent Microbiol; 2016 Apr 09; 48(4):298-302. PubMed ID: 27567523
    [Abstract] [Full Text] [Related]

  • 10. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I.
    Infect Control Hosp Epidemiol; 2007 Sep 09; 28(9):1054-9. PubMed ID: 17932826
    [Abstract] [Full Text] [Related]

  • 11. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
    Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD.
    Am J Infect Control; 1995 Jun 09; 23(3):170-80. PubMed ID: 7677262
    [Abstract] [Full Text] [Related]

  • 12. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
    Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D.
    Clin Microbiol Infect; 2012 Apr 09; 18(4):388-94. PubMed ID: 21848977
    [Abstract] [Full Text] [Related]

  • 13. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN, Arnold RS, Gammie JS, Gilliam BL.
    J Infect; 2011 Dec 09; 63(6):420-8. PubMed ID: 21920382
    [Abstract] [Full Text] [Related]

  • 14. [Vancomycin resistant enterococci in Austria].
    Allerberger F, Lass-Flörl C, Dierich MP, Hirschl AM, Presterl E, Haas G, Klare I, Witte W.
    Wien Klin Wochenschr; 1997 May 09; 109(9):312-20. PubMed ID: 9265389
    [Abstract] [Full Text] [Related]

  • 15. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA, Mickail N, Eisenstein L.
    Heart Lung; 2007 May 09; 36(6):456-61. PubMed ID: 18005808
    [Abstract] [Full Text] [Related]

  • 16. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA, Shay DK, Patel P, Tacsa L, Maloney SA, Jarvis WR, Wormser GP.
    Arch Intern Med; 1996 Jul 08; 156(13):1458-62. PubMed ID: 8678715
    [Abstract] [Full Text] [Related]

  • 17. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients.
    Wells CL, Juni BA, Cameron SB, Mason KR, Dunn DL, Ferrieri P, Rhame FS.
    Clin Infect Dis; 1995 Jul 08; 21(1):45-50. PubMed ID: 7578758
    [Abstract] [Full Text] [Related]

  • 18. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
    Cho SY, Lee DG, Choi SM, Kwon JC, Kim SH, Choi JK, Park SH, Park YJ, Choi JH, Yoo JH.
    BMC Infect Dis; 2013 Oct 29; 13():504. PubMed ID: 24164924
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
    Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee DW, Kamatam S, Bathina P, Nanjireddy P, Chalana IK, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS.
    Antimicrob Agents Chemother; 2012 May 29; 56(5):2452-8. PubMed ID: 22354290
    [Abstract] [Full Text] [Related]

  • 20. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
    Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, Kusne S.
    Clin Infect Dis; 1996 Apr 29; 22(4):663-70. PubMed ID: 8729206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.